<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet href="http://feeds.drugs.com/~d/styles/rss2full.xsl" type="text/xsl" media="screen"?><?xml-stylesheet href="http://feeds.drugs.com/~d/styles/itemcontent.css" type="text/css" media="screen"?><rss xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="0.91">
<channel>
	<title>Drugs.com - FDA MedWatch Alerts</title>
	<link>http://www.drugs.com/fda_alerts.html</link>
	<description>Latest alerts to consumers and health care providers warning of recently identified adverse effects associated with currently available drugs and supplements.</description>
	<language>en</language>

	<image><link>http://www.drugs.com/</link><url>http://www.drugs.com/img/drugscom-feedburner.gif</url><title>Drugs.com</title></image><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" href="http://feeds.drugs.com/Drugscom-FdaMedwatchAlerts" type="application/rss+xml" /><item>
		<title>Phenytoin (marketed as Dilantin, Phenytek and generics) and Fosphenytoin Sodium (marketed as Cerebyx and generics)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/464254295/phenytoin-marketed-dilantin-phenytek-generics-fosphenytoin-sodium-marketed-cerebyx-generics-12469.html</link>
		<description>Audience: Neurological healthcare professionals[Posted 11/24/2008] FDA is investigating new preliminary data regarding a potential increased risk of serious skin reactions including Stevens Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN)...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/464254295" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 24 Nov 2008 05:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/phenytoin-marketed-dilantin-phenytek-generics-fosphenytoin-sodium-marketed-cerebyx-generics-12469.html</feedburner:origLink></item>

	<item>
		<title>Animas Corporation Battery Caps Used with the OneTouch Ping System, Animas 2020 Insulin Pump, Animas IR1200 Insulin Pump, and Animas IR1250 Insulin Pump</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/461251141/animas-corporation-battery-caps-onetouch-ping-animas-2020-insulin-pump-animas-ir1200-insulin-pump-12468.html</link>
		<description>Audience: Consumers, endocrinological healthcare professionals
[Posted 11/20/2008] Animas Corporation and FDA informed consumers and healthcare professionals of a nationwide recall of battery caps used with the OneTouch Ping System, Animas 2020...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/461251141" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 20 Nov 2008 05:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/animas-corporation-battery-caps-onetouch-ping-animas-2020-insulin-pump-animas-ir1200-insulin-pump-12468.html</feedburner:origLink></item>

	<item>
		<title>Benzoyl Peroxide Acne Cream 10% marked as: DG Maximum Strength Acne Medicated Gel; Kroger Acne Gel 10% Benzoyl Peroxide Acne Medication; Equate: Medicated Acne Gel</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/456470505/benzoyl-peroxide-acne-cream-10-marked-dg-maximum-acne-medicated-gel-kroger-acne-gel-10-benzoyl-12467.html</link>
		<description>Audience: Consumers, dermatologists, pharmacists, other healthcare professionals[Posted 11/17/2008] CSI USA Inc. and FDA informed consumers and healthcare professionals of a nationwide recall of all lots of 1 ounce tubes of 10% Benzoyl Peroxide Acne...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/456470505" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 17 Nov 2008 05:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/benzoyl-peroxide-acne-cream-10-marked-dg-maximum-acne-medicated-gel-kroger-acne-gel-10-benzoyl-12467.html</feedburner:origLink></item>

	<item>
		<title>Infants' Mylicon Gas Relief Dye Free Drops (Simethicone-Antigas)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/451174960/infants-mylicon-gas-relief-dye-free-drops-simethicone-antigas-12466.html</link>
		<description>Audience: Consumers, pediatricians, other healthcare professionals[Posted 11/12/2008] Johnson &amp;amp; Johnson, Merck Consumer Pharmaceuticals Company and FDA notified consumers and healthcare professionals of a voluntary recall of Infants' Mylicon Gas...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/451174960" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 12 Nov 2008 05:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/infants-mylicon-gas-relief-dye-free-drops-simethicone-antigas-12466.html</feedburner:origLink></item>

	<item>
		<title>Update on Early Communication: Bisphosphonates marketed as Alendronate (Fosamax, Fosamax Plus D); Etidronate (Didronel); Ibandronate (Boniva); Pamidronate (Aredia); Risedronate (Actonel, Actonel W/Calcium); Tiludronate (Skelid); Zoledronic acid (Reclast, Zometa)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/451174963/update-early-communication-bisphosphonates-marketed-alendronate-fosamax-fosamax-plus-d-etidronate-12465.html</link>
		<description>Audience: Geriatricians, gynecologists, orthopedic surgeons, other healthcare professionals[Posted 11/12/2008] FDA issued an update to the Agency's review of safety data regarding the potential increased risk of atrial fibrillation in patients...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/451174963" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 12 Nov 2008 05:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/update-early-communication-bisphosphonates-marketed-alendronate-fosamax-fosamax-plus-d-etidronate-12465.html</feedburner:origLink></item>

	<item>
		<title>Propafenone HCl Tablets (150 mg, 225 mg, 300 mg), Isosorbide Mononitrate Extended Release Tablets (30 mg and 60 mg), Morphine Sulfate Extended Release Tablets (15 mg), Morphine Sulfate Immediate Release Tablets (15 mg and 30 mg), Dextroamphetamine Sulfate Tablets (10 mg)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/450025204/propafenone-hcl-150-mg-225-mg-300-mg-isosorbide-mononitrate-extended-release-30-mg-60-mg-morphine-12464.html</link>
		<description>Audience: Pharmacists, other healthcare professionals, patients
[Posted 11/10/2008] Ethex Corp and FDA notified healthcare professionals of a voluntary recall of five generic products (Propafenone HCl Tablets, Isosorbide Mononitrate Extended Release...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/450025204" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 10 Nov 2008 05:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/propafenone-hcl-150-mg-225-mg-300-mg-isosorbide-mononitrate-extended-release-30-mg-60-mg-morphine-12464.html</feedburner:origLink></item>

	<item>
		<title>ReliOn Insulin Syringes for use with U-100 Insulin (Tyco Healthcare - Covidien)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/444796166/relion-insulin-syringes-u-100-insulin-tyco-healthcare-covidien-12442.html</link>
		<description>Audience: Patients with insulin-dependent diabetes; pharmacists[Posted 11/06/2008] Covidien and FDA notified patients and healthcare professionals of a recall of ReliOn sterile, single-use, disposable, hypodermic syringes with permanently affixed...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/444796166" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 06 Nov 2008 05:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/relion-insulin-syringes-u-100-insulin-tyco-healthcare-covidien-12442.html</feedburner:origLink></item>

	<item>
		<title>Raptiva (efalizumab)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/424089979/raptiva-efalizumab-12438.html</link>
		<description>Audience: Dermatological healthcare professionals, patients[Posted 10/17/2008] FDA notified healthcare professionals of extensive labeling changes, including a Boxed Warning, to highlight the risks of life-threatening infections, including bacterial...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/424089979" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 17 Oct 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/raptiva-efalizumab-12438.html</feedburner:origLink></item>

	<item>
		<title>Dextroamphetamine Sulfate 5mg Tablets</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/423094681/dextroamphetamine-sulfate-5mg-tablets-12437.html</link>
		<description>Audience: Pharmacists, other healthcare professionals, patients[Posted 10/16/2008] Ethex Corp and FDA notified healthcare professionals of a voluntary recall of three lots of Dextroamphetamine Sulfate 5mg tablets. The product was recalled due to the...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/423094681" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 16 Oct 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/dextroamphetamine-sulfate-5mg-tablets-12437.html</feedburner:origLink></item>

	<item>
		<title>Over The Counter Cough and Cold Medications</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/416378177/over-counter-cough-cold-medications-12436.html</link>
		<description>Audience: Pediatric and primary healthcare professionals, consumers
[Posted 10/09/2008] FDA notified healthcare professionals and consumers that the Consumer Healthcare Products Association (CHPA) is voluntarily modifying the product labels for...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/416378177" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 09 Oct 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/over-counter-cough-cold-medications-12436.html</feedburner:origLink></item>

	<item>
		<title>Tiotropium (marketed as Spiriva HandiHaler)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/414121060/tiotropium-marketed-spiriva-handihaler-12435.html</link>
		<description>Audience: Pulmonary care health professionals and patients[UPDATE 10/07/2008] FDA informed healthcare professionals that FDA has reviewed preliminary data from UPLIFT (Understanding the Potential Long-Term Impacts on Function with Tiotropium), a...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/414121060" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 07 Oct 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/tiotropium-marketed-spiriva-handihaler-12435.html</feedburner:origLink></item>

	<item>
		<title>Nebion HLX-8 Magnetic Resonance Device</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/411449480/nebion-hlx-8-magnetic-resonance-device-12434.html</link>
		<description>Audience: Healthcare professionals, consumers
[Posted 10/03/2008] FDA notified healthcare professionals of a Class I Recall of the Nebion HLX-8 Magnetic Resonance Device. The manufacturer of the device made unsupported claims that the product could...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/411449480" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 03 Oct 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/nebion-hlx-8-magnetic-resonance-device-12434.html</feedburner:origLink></item>

	<item>
		<title>Medtronic Neuromodulation INDURA One-Piece Intrathecal Catheters, Sutureless Pump Connector Revision Kit, Intrathecal Catheter Pump Segment Revision Kit</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/409627082/medtronic-neuromodulation-indura-one-piece-intrathecal-catheters-sutureless-pump-connector-revision-12433.html</link>
		<description>Audience: Physical medicine and rehabilitation specialists, anesthesia healthcare professionals, hospital surgical service managers
[Posted 10/02/2008] Medtronic and FDA notified healthcare professionals of the Class I Recall of several Medtronic...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/409627082" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 02 Oct 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/medtronic-neuromodulation-indura-one-piece-intrathecal-catheters-sutureless-pump-connector-revision-12433.html</feedburner:origLink></item>

	<item>
		<title>Statin drugs and amyotrophic lateral sclerosis (ALS)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/407536731/statin-amyotrophic-lateral-sclerosis-als-12432.html</link>
		<description>Audience: Neurologists, cardiologists, consumers[Posted 09/30/2008] An FDA analysis provides new evidence that the use of statins does not increase incidence of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease often referred to as...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/407536731" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 30 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/statin-amyotrophic-lateral-sclerosis-als-12432.html</feedburner:origLink></item>

	<item>
		<title>Epoetin alfa</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/404125703/epoetin-alfa-12431.html</link>
		<description>Audience: Neurological healthcare professionalsPosted 09/23/2008] FDA has been made aware of preliminary safety findings from a clinical trial conducted in Germany investigating the use of epoetin alfa to treat acute ischemic stroke. The clinical...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/404125703" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 26 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/epoetin-alfa-12431.html</feedburner:origLink></item>

	<item>
		<title>Tarceva (erlotinib)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/401055299/tarceva-erlotinib-12430.html</link>
		<description>Audience: Oncological healthcare professionals[Posted 09/23/2008] OSI and Genentech notified healthcare professionals that cases of hepatic failure and hepatorenal syndrome, including fatalities, have been reported during use of Tarceva,...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/401055299" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 23 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/tarceva-erlotinib-12430.html</feedburner:origLink></item>

	<item>
		<title>Ammonul (sodium phenylacetate and sodium benzoate) Injection 10%/10%</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/401055298/ammonul-sodium-phenylacetate-sodium-benzoate-10-10-12429.html</link>
		<description>Audience: Hospital ER and ICU medical and nursing personnel, risk managersPosted 09/23/2008] Ucyclyd Pharma, Inc. informed healthcare professionals of the detection of particulate matter in the Ammonul Injection product. This particulate matter may...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/401055298" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 23 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/ammonul-sodium-phenylacetate-sodium-benzoate-10-10-12429.html</feedburner:origLink></item>

	<item>
		<title>Infant Formula Manufactured in China Contaminated With Melamine</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/400111945/infant-formula-manufactured-china-contaminated-melamine-12428.html</link>
		<description>Audience: Consumers, pediatricians
[UPDATE 09/22/2008] FDA contacted companies who manufacture infant formula for distribution in the United States and has learned that they are not importing formula or source materials from China. FDA, in...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/400111945" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 22 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/infant-formula-manufactured-china-contaminated-melamine-12428.html</feedburner:origLink></item>

	<item>
		<title>Phosphocol P 32 (Chromic Phosphate P 32 Suspension)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/396532688/phosphocol-p-32-chromic-phosphate-p-32-suspension-12427.html</link>
		<description>Audience: Oncologists, other healthcare professionals[Posted 09/18/2008] Covidien and Mallinckrodt Inc. informed healthcare professionals of important new safety information in prescribing Phosphocol P 32. Phosphocol P 32 is approved for the...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/396532688" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 18 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/phosphocol-p-32-chromic-phosphate-p-32-suspension-12427.html</feedburner:origLink></item>

	<item>
		<title>LifePak CR Plus Automated External Defibrillators</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/394507262/lifepak-cr-plus-automated-external-defibrillators-12426.html</link>
		<description>Audience: Emergency medical personnel, other healthcare professionals
[Posted 09/11/2008] Physio Control, Inc., issued a recall of LifePak CR Plus Automated External Defibrillators (AED), used by emergency or medical personnel to treat adults in...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/394507262" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 16 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/lifepak-cr-plus-automated-external-defibrillators-12426.html</feedburner:origLink></item>

	<item>
		<title>Infant Formula Manufactured in China</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/390990000/infant-formula-manufactured-china-12425.html</link>
		<description>Audience: Consumers, pediatricians, other healthcare professionals
[Posted 09/12/2008] FDA issued a Health Information Advisory to consumers and healthcare professionals regarding milk-based infant formula manufactured in China. The Chinese...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/390990000" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 12 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/infant-formula-manufactured-china-12425.html</feedburner:origLink></item>

	<item>
		<title>Rituxan (rituximab)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/390055375/rituxan-rituximab-12424.html</link>
		<description>Audience: Oncologists, rheumatologists, other healthcare professionals, consumers[Posted 09/11/2008] Genentech informed healthcare professionals of revisions to prescribing information for Rituxan regarding a case of progressive multifocal...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/390055375" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 11 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/rituxan-rituximab-12424.html</feedburner:origLink></item>

	<item>
		<title>LifePak CR Plus Automated External Defibrillators</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/390055373/lifepak-cr-plus-automated-external-defibrillators-12423.html</link>
		<description>Audience: Emergency medical personnel, other healthcare professionals
[Posted 09/11/2008] Physio Control, Inc., issued a recall of LifePak CR Plus Automated External Defibrillators (AED), used by emergency or medical personnel to treat adults in...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/390055373" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 11 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/lifepak-cr-plus-automated-external-defibrillators-12423.html</feedburner:origLink></item>

	<item>
		<title>Disposable Battery Operated Lavage System (BOLS)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/387963881/disposable-battery-operated-lavage-bols-12422.html</link>
		<description>Audience: Operating room, outpatient and emergency room supervisory staff and physicians, risk managers
[Posted 09/08/2008] FDA notified healthcare professionals about the potential for sparks, fires, toxic fumes, and explosions when disposable...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/387963881" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 08 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/disposable-battery-operated-lavage-bols-12422.html</feedburner:origLink></item>

	<item>
		<title>Tumor necrosis factor-alpha blockers (TNF blockers), Cimzia (certolizumab pegol), Enbrel (etanercept), Humira (adalimumab), and Remicade (infliximab) </title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/383579589/tumor-necrosis-factor-alpha-blockers-tnf-blockers-cimzia-certolizumab-pegol-enbrel-etanercept-12420.html</link>
		<description>Audience: Rheumatological, gastroenterological and infectious disease healthcare professionals[Posted 09/04/2008] FDA notified healthcare professionals that pulmonary and disseminated histoplasmosis, coccidioidomycosis, blastomycosis and other...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/383579589" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 04 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/tumor-necrosis-factor-alpha-blockers-tnf-blockers-cimzia-certolizumab-pegol-enbrel-etanercept-12420.html</feedburner:origLink></item>

	<item>
		<title>Pacific Consolidated brand Mobile Oxygen Storage Tank</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/377426003/pacific-consolidated-brand-mobile-oxygen-storage-tank-12419.html</link>
		<description>Audience: Emergency healthcare professionals, military emergency/disaster/field hospital/aviation personnel [Posted 08/28/2008] Pacific Consolidated Industries, LLC, and FDA notified healthcare professionals of the Class I Recall of the Mobile...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/377426003" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 01 Sep 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/pacific-consolidated-brand-mobile-oxygen-storage-tank-12419.html</feedburner:origLink></item>

	<item>
		<title>Tysabri (natalizumab)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/374577543/tysabri-natalizumab-12418.html</link>
		<description>Audience: Neurologists, other healthcare professionals, patients[Posted 08/25/2008] FDA informed healthcare professionals of two new cases of progressive multifocal leukoencephalopathy (PML) in European patients receiving Tysabri monotherapy for...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/374577543" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 25 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/tysabri-natalizumab-12418.html</feedburner:origLink></item>

	<item>
		<title>Ezetimibe/Simvastatin (Vytorin); Simvastatin (Zocor); and Ezetimibe (Zetia)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/371317183/ezetimibe-simvastatin-vytorin-simvastatin-zocor-ezetimibe-zetia-12417.html</link>
		<description>Audience: Endocrinologists, cardiologists, other healthcare professionals, patients[Posted 08/21/2008] FDA informed healthcare professionals that the Agency is investigating a report from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) trial...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/371317183" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 21 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/ezetimibe-simvastatin-vytorin-simvastatin-zocor-ezetimibe-zetia-12417.html</feedburner:origLink></item>

	<item>
		<title>Byetta (exenatide)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/374722985/byetta-exenatide-12186.html</link>
		<description>Audience: Endocrinologists, other healthcare professionals, consumers[UPDATED 08/18/2008] Since issuing Information for Healthcare Professionals in October 2007, FDA has received reports of 6 cases of hemorrhagic or necrotizing pancreatitis in...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/374722985" height="1" width="1"/&gt;</description>
		<pubDate>Mon, 18 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/byetta-exenatide-12186.html</feedburner:origLink></item>

	<item>
		<title>Boston Scientific NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/365040507/boston-scientific-nexstent-monorail-nexstent-carotid-stent-monorail-delivery-system-12416.html</link>
		<description>Audience: Cardiologists, hospital risk managers [Posted 08/14/2008] Boston Scientific and FDA informed healthcare professionals and patients of the Class I Recall of NexStent Monorail, NexStent Carotid Stent and Monorail Delivery System, distributed...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/365040507" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 14 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/boston-scientific-nexstent-monorail-nexstent-carotid-stent-monorail-delivery-system-12416.html</feedburner:origLink></item>

	<item>
		<title>Fentanyl Transdermal System CII Patches</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/363356063/fentanyl-transdermal-cii-patches-12415.html</link>
		<description>Audience: Pain management specialists, risk managers, other healthcare professionals, patients[UPDATED 08/12/2008] Watson Pharmaceuticals, Inc., issued a voluntary recall of one lot of 75mcg/hr Fentanyl Transdermal System patches (lot 92461850;...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/363356063" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 12 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/fentanyl-transdermal-cii-patches-12415.html</feedburner:origLink></item>

	<item>
		<title>Vivitrol (naltrexone)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/363356062/vivitrol-naltrexone-12414.html</link>
		<description>Audience: Primary healthcare physicians, internists, other healthcare professionals[Posted 08/12/2008] FDA informed healthcare professionals of the risk of adverse injection site reactions in patients receiving naltrexone. Naltrexone is indicated...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/363356062" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 12 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/vivitrol-naltrexone-12414.html</feedburner:origLink></item>

	<item>
		<title>Simvastatin Used With Amiodarone</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/359765388/simvastatin-amiodarone-12413.html</link>
		<description>Audience: Cardiologic healthcare professionals, pharmacists, other healthcare professionals[Posted 08/08/2008] FDA notified healthcare professionals of the risk of muscle injury, rhabdomyolysis, which can lead to kidney failure or death, when...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/359765388" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 08 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/simvastatin-amiodarone-12413.html</feedburner:origLink></item>

	<item>
		<title>Levitronix CentriMag Extracorporeal Blood Pumping System: CentriMag Primary Console (with v200 Application Software)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/353195271/levitronix-centrimag-extracorporeal-blood-pumping-centrimag-primary-console-v200-application-12411.html</link>
		<description>Audience: Cardiothoracic healthcare professionals, perfusionists,&amp;nbsp;hospital risk managers, biomedical engineers [Posted 08/01/2008] Levitronix and FDA notified healthcare professionals of a Class 1 recall of the Levitronix CentriMag...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/353195271" height="1" width="1"/&gt;</description>
		<pubDate>Fri, 01 Aug 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/levitronix-centrimag-extracorporeal-blood-pumping-centrimag-primary-console-v200-application-12411.html</feedburner:origLink></item>

	<item>
		<title>Erythropoiesis Stimulating Agents (ESAs) - Epoetin alfa (marketed as Procrit, Epogen), Darbepoetin alfa (marketed as Aranesp)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/351892754/erythropoiesis-stimulating-agents-esas-epoetin-alfa-marketed-procrit-epogen-darbepoetin-alfa-12409.html</link>
		<description>Audience: Oncologists, other healthcare professionals[Posted 07/31/2008] Amgen and FDA informed healthcare professionals of modifications to certain sections of the Boxed Warnings, Indications and Usage, and Dosage and Administration sections of...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/351892754" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 31 Jul 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/erythropoiesis-stimulating-agents-esas-epoetin-alfa-marketed-procrit-epogen-darbepoetin-alfa-12409.html</feedburner:origLink></item>

	<item>
		<title>Viapro 375mg Capsules</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/351892753/viapro-375mg-capsules-12408.html</link>
		<description>Audience: Consumers, healthcare professionals [Posted 07/31/2008] EG Labs, LLC, notified consumers and healthcare professionals not to buy or use Viapro 375mg Capsules because one lot of the product was found to contain a potentially harmful...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/351892753" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 31 Jul 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/viapro-375mg-capsules-12408.html</feedburner:origLink></item>

	<item>
		<title>Rize 2 The Occasion Capsules, Rose 4 Her Capsules</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/351892755/rize-2-occasion-capsules-rose-4-her-capsules-12410.html</link>
		<description>Audience: Consumers, healthcare professionals [UPDATE 07/30/2008] Jack Distribution, LLC, announced a nationwide recall of all lot numbers of the company's supplement products sold under the brand names Rize 2 The Occasion and Rose 4 Her. Lab...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/351892755" height="1" width="1"/&gt;</description>
		<pubDate>Wed, 30 Jul 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/rize-2-occasion-capsules-rose-4-her-capsules-12410.html</feedburner:origLink></item>

	<item>
		<title>Mitoxantrone Hydrochloride (marketed as Novantrone and generics)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/349852252/mitoxantrone-hydrochloride-marketed-novantrone-generics-12407.html</link>
		<description>Audience: Neurological and Oncological healthcare professionals, risk managers[Posted 07/29/2008] FDA reminded health care professionals who treat patients with mitoxantrone about recommendations that left ventricular ejection fraction (LVEF) be...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/349852252" height="1" width="1"/&gt;</description>
		<pubDate>Tue, 29 Jul 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/mitoxantrone-hydrochloride-marketed-novantrone-generics-12407.html</feedburner:origLink></item>

	<item>
		<title>Abacavir (marketed as Ziagen) and Abacavir-containing Medications</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/344994952/abacavir-marketed-ziagen-abacavir-containing-medications-12406.html</link>
		<description>Audience: Infectious disease and medical genetics healthcare professionals[Posted 07/24/2008] FDA informed healthcare professionals that serious and sometimes fatal hypersensitivity reactions (HSR) caused by abacavir therapy are significantly more...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/344994952" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 24 Jul 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/abacavir-marketed-ziagen-abacavir-containing-medications-12406.html</feedburner:origLink></item>

	<item>
		<title>Micro-bubble Contrast Agents (marketed as Definity (Perflutren Lipid Microsphere) Injectable Suspension and Optison (Perflutren Protein-Type A Microspheres for Injection)</title>
		<link>http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~3/339290975/micro-bubble-contrast-agents-marketed-definity-perflutren-lipid-microsphere-injectable-suspension-12405.html</link>
		<description>Audience: Radiological healthcare professionals, cardiologists, hospital risk managers [Posted 07/17/2008] FDA is updating healthcare professionals about recent changes made to the Boxed Warning, Warnings, and Contraindications sections of the...&lt;img src="http://feeds.drugs.com/~r/Drugscom-FdaMedwatchAlerts/~4/339290975" height="1" width="1"/&gt;</description>
		<pubDate>Thu, 17 Jul 2008 04:00:00 GMT</pubDate>
	<feedburner:origLink>http://www.drugs.com/fda/micro-bubble-contrast-agents-marketed-definity-perflutren-lipid-microsphere-injectable-suspension-12405.html</feedburner:origLink></item>
</channel>
</rss>
